Lunai Bioworks Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LNAI | CLDI | NIKI | KALA | GRI | PCSA | |
|---|---|---|---|---|---|---|
| Market cap | 829.68K | 2.68M | 5.27M | 3.44M | 3.13M | 5.41M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -0.8 | — | 0.0 | -0.7 | -0.5 |
| Price/book | -0.1 | 0.5 | 0.1 | 0.4 | 0.3 | -17.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −97.98% | −97.25% | −87.62% | −99.51% | −97.10% | −75.51% |
| Today | 0.00% | −2.54% | −3.98% | +2.95% | −7.14% | −0.26% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All LNAI news ›Lunai Bioworks plans Nasdaq delisting
Lunai Bioworks (LNAI) received a Nasdaq delisting determination after failing to meet the exchange’s $2.5M minimum stockholders’ equity requirement. - Lunai Bioworks (LNAI) received a Nasdaq delisting determination after failing to meet…
Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister
--Lunai Bioworks Inc. announced that on October 21, 2026, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC stating that the Company no longer complies with Nasdaq Listing Rule 5550, which…
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split
Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid Price Stockholders who hold shares electronically in book-entry form with Securities Transfer Corporation, the Company's transfer agent, will not need to take action…
Lunai Bioworks has under a month of cash under current plan
As of October 13, 2026, Lunai said it had less than one month of available cash resources under its current operating plan. The audited annual report says the $1.84 million Neurobridge acquisition was paid for with eight Series B preferred…
Lunai Bioworks Seeks Nasdaq Trading Suspension Amid Probe
Lunai Bioworks ( (LNAI) ) has issued an update. More about Lunai Bioworks Lunai Bioworks, Inc. is a biotechnology company whose common stock is listed on Nasdaq, giving it exposure to public equity markets and to trading practices…
Lunai Bioworks asks Nasdaq to halt trading amid alleged irregular short-selling
TradingView Lunai Bioworks asks Nasdaq to halt trading amid alleged irregular short-selling Lunai Bioworks requested Nasdaq immediately suspend trading in its common stock while alleged irregular trading is reviewed. -
[8-K] Lunai Bioworks Inc. Reports Material Event
Btab Defines Its Vision as a Generational Project for the AI Era Datavault AI to Attend the 2026 Maxim Growth Summit Lunai submitted a request to Nasdaq to immediately suspend trading in its common stock, but Nasdaq had made no decision as…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com2
- stocktitan.net2
- markets.financialcontent.com1
- prnewswire.com1
- theglobeandmail.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.